11.04.2016 • News

Roquette Receives EXCiPACT Certification

Roquette has recently obtained EXCiPACT certification from SGS France, one of the international auditors authorized to grant approval under this standard.

The certificate demonstrates that the Roquette site at Lestrem, France, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) certification standard. Its scope includes the design, production and storage of excipients made from amylaceous substances such as certain starches and glucoses, sorbitol, maltitol, mannitol and xylitol powders, and maltitol solutions.

EXCiPACT certification ensures top-level quality throughout the entire supply chain and gives customers access to the full documentation mandatory to the regulators.

“This certification is a new milestone in our commitment to customers” said Paul Smaltz, Roquette’s head of Pharma global business unit. “Roquette wants to offer best-in-class services to its customers, and the EXCiPACT certification was a must-have to us. The implementation of quality and safety best practices as required by EXCiPACT offers our customers the possibility to significantly reduce the number of audits. It means for them cost and time savings, while enjoying premium quality products.”

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.